Tamoxifen protects against obesity-related metabolic disorders
Thursday, May 11, 2017 - 05:32
in Health & Medicine
Tamoxifen, a selective estrogen receptor modulator, is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer. Tamoxifen is also known to have metabolic effects. A new study in The American Journal of Pathology ... Read more